J. Lipid Res. Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M500502-JLR200 on January 28, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500502-JLR200v1
47/4/794    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nofer, J.-R.
Right arrow Articles by Assmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nofer, J.-R.
Right arrow Articles by Assmann, G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 794-803, April 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter

Jerzy-Roch Nofer*,{dagger},1, Alan T. Remaley§, Renata Feuerborn{dagger}, Iza Wolinnska*, Thomas Engel{dagger}, Arnold von Eckardstein** and Gerd Assmann*,{dagger}

* Institut für Klinische Chemie und Laboratoriumsmedizin, Westfälische Wilhelms-Universität, Münster, Germany
{dagger} Leibniz-Institut für Arterioskleroseforschung an der Universität Münster, Münster, Germany
§ Department of Laboratory Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD
** Institut für Klinische Chemie, Universitäts-Spital Zürich, Zürich, Switzerland

Published, JLR Papers in Press, January 28, 2006.

1 To whom correspondence should be addressed. e-mail: nofer{at}uni-muenster.de

It has been suggested that the signal transduction initiated by apolipoprotein A-I (apoA-I) activates key proteins involved in cholesterol efflux. ABCA1 serves as a binding partner for apoA-I, but its participation in apoA-I-induced signaling remains uncertain. We show that the exposure of human fibroblasts to ABCA1 ligands (apolipoproteins and amphipathic helical peptides) results in the generation of intracellular signals, including activation of the small G-protein Cdc42, protein kinases (PAK-1 and p54JNK), and actin polymerization. ApoA-I-induced signaling was abrogated by glyburide, an inhibitor of the ABC transporter family, and in fibroblasts from patients with Tangier disease, which do not express ABCA1. Conversely, induction of ABCA1 expression with the liver X receptor agonist, T0901317, and the retinoid X receptor agonist, R0264456, potentiated apoA-I-induced signaling. Similar effects were observed in HEK293 cells overexpressing ABCA1-green fluorescent protein (GFP) fusion protein, but not ABCA1-GFP (K939M), which fails to hydrolyze ATP, or a nonfunctional ABCA1-GFP with a truncated C terminus. We further found that Cdc42 coimmunoprecipitates with ABCA1 in ABCA1-GFP-expressing HEK293 cells exposed to apoA-I but not in cells expressing ABCA1 mutants. We conclude that ABCA1 transduces signals from apoA-I by complexing and activating Cdc42 and downstream kinases and, therefore, acts as a full apoA-I receptor.

Supplementary key words ATP binding cassette transporter A1 • high density lipoproteins • cholesterol efflux

Abbreviations: apoA-I, apolipoprotein A-I; GEF, GDP exchange factor; GFP, green fluorescent protein; GST-PBD, glutathione S-transferase-p21 binding domain; JAK2, Janus kinase 2; LXR, liver X receptor; PC, phosphatidylcholine; PKA, protein kinase A; PKC, protein kinase C; RXR, retinoid X receptor; WS, Werner syndrome


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
X. Zheng, L. Hong, L. Shi, J. Guo, Z. Sun, and J. Zhou
Proteomics Analysis of Host Cells Infected with Infectious Bursal Disease Virus
Mol. Cell. Proteomics, March 1, 2008; 7(3): 612 - 625.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
X. Wang, H. Mu, H. Chai, D. Liao, Q. Yao, and C. Chen
Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Cholesterol Efflux from Human Macrophage-Derived Foam Cells
Am. J. Pathol., July 1, 2007; 171(1): 304 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. D. Linder, R.-L. Uronen, M. Holtta-Vuori, P. van der Sluijs, J. Peranen, and E. Ikonen
Rab8-dependent Recycling Promotes Endosomal Cholesterol Removal in Normal and Sphingolipidosis Cells
Mol. Biol. Cell, January 1, 2007; 18(1): 47 - 56.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.